Abdel‐Naser Elzouki

1.8k total citations · 1 hit paper
120 papers, 933 citations indexed

About

Abdel‐Naser Elzouki is a scholar working on Epidemiology, Surgery and Infectious Diseases. According to data from OpenAlex, Abdel‐Naser Elzouki has authored 120 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 30 papers in Surgery and 23 papers in Infectious Diseases. Recurrent topics in Abdel‐Naser Elzouki's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (11 papers) and COVID-19 Clinical Research Studies (10 papers). Abdel‐Naser Elzouki is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (11 papers) and COVID-19 Clinical Research Studies (10 papers). Abdel‐Naser Elzouki collaborates with scholars based in Qatar, United States and Libya. Abdel‐Naser Elzouki's co-authors include Fahmi Yousef Khan, Elmukhtar Habas, Mohammed Danjuma, Mohsen Eledrisi, Ibrahim Taher, Khalifa Sifaw Ghenghesh, Mohammed Imad Malki, Mouhand Mohamed, Abdul‐Badi Abou‐Samra and Omar Elahmer and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

Abdel‐Naser Elzouki

102 papers receiving 902 citations

Hit Papers

Metabolic-associated fatty liver disease: a selective rev... 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdel‐Naser Elzouki Qatar 16 278 220 167 114 100 120 933
Andrea Dalbeni Italy 18 458 1.6× 361 1.6× 145 0.9× 132 1.2× 181 1.8× 82 1.3k
Andrew Atkinson Switzerland 19 260 0.9× 197 0.9× 208 1.2× 42 0.4× 117 1.2× 103 1.2k
Kenneth J. Wilkins United States 19 239 0.9× 188 0.9× 236 1.4× 89 0.8× 242 2.4× 46 1.0k
Vijay Gayam United States 16 301 1.1× 385 1.8× 336 2.0× 124 1.1× 110 1.1× 127 1.3k
Jeffrey S. Jhang United States 17 151 0.5× 213 1.0× 199 1.2× 61 0.5× 142 1.4× 33 1.1k
Piyush Srivastava Australia 22 173 0.6× 191 0.9× 183 1.1× 46 0.4× 136 1.4× 72 1.4k
I‐Jung Tsai Taiwan 20 199 0.7× 245 1.1× 183 1.1× 53 0.5× 176 1.8× 78 1.3k
Valentina Perrone Italy 19 177 0.6× 118 0.5× 154 0.9× 32 0.3× 85 0.8× 128 1.1k
Tinsay A. Woreta United States 13 277 1.0× 113 0.5× 115 0.7× 195 1.7× 49 0.5× 39 644

Countries citing papers authored by Abdel‐Naser Elzouki

Since Specialization
Citations

This map shows the geographic impact of Abdel‐Naser Elzouki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdel‐Naser Elzouki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdel‐Naser Elzouki more than expected).

Fields of papers citing papers by Abdel‐Naser Elzouki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdel‐Naser Elzouki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdel‐Naser Elzouki. The network helps show where Abdel‐Naser Elzouki may publish in the future.

Co-authorship network of co-authors of Abdel‐Naser Elzouki

This figure shows the co-authorship network connecting the top 25 collaborators of Abdel‐Naser Elzouki. A scholar is included among the top collaborators of Abdel‐Naser Elzouki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdel‐Naser Elzouki. Abdel‐Naser Elzouki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almahmeed, Wael, Fatheya Alawadi, Mostafa Q. Alshamiri, et al.. (2025). Improving Therapeutic Adherence and Reducing Therapeutic Inertia in the Management of People with Cardiometabolic Diseases: A Call-to-Action from the Middle East. Advances in Therapy. 42(3). 1340–1359. 1 indexed citations
2.
El‐Kassas, Mohamed, Marcela Villota‐Rivas, Khalid Alswat, et al.. (2025). Metabolic Dysfunction‐Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority Agenda. Liver International. 45(6). e70108–e70108. 2 indexed citations
3.
El‐Kassas, Mohamed, Khalid Alswat, Asma Labidi, et al.. (2025). Frailty and MASLD in the Arab region: An urgent call for regional clinical and public health strategies. Arab Journal of Gastroenterology. 26(4). 315–317.
4.
Zahid, Muhammad, et al.. (2025). Hepatic vena cava syndrome: a case report and literature review. Oxford Medical Case Reports. 2025(5). omaf035–omaf035.
5.
Abdallah, Abdallah M., Hifzur Rahman Ansari, Muhammad Shuaib, et al.. (2025). Immune transcriptomic analysis on COVID-19 patients with varying clinical presentations identifies severity markers. Scientific Reports. 15(1). 23416–23416.
6.
Habas, Elmukhtar, et al.. (2024). Masked phenomenon: renal and cardiovascular complications; review and updates. Blood Pressure. 33(1). 2383234–2383234.
8.
Malki, Mohammed Imad, et al.. (2024). Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Frontiers in Medicine. 11. 1291501–1291501. 40 indexed citations breakdown →
9.
Habas, Elmukhtar, et al.. (2024). Diagnostic approach to pleural effusion based on pathogenesis and radiological findings: A narrative review. 3(2). 102–113. 1 indexed citations
10.
Danjuma, Mohammed, et al.. (2023). Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses. Heliyon. 9(10). e20155–e20155. 3 indexed citations
11.
Elzouki, Abdel‐Naser, Hanan F. Abdul Rahim, Lukman Thalib, et al.. (2023). Validation of a Risk Prediction Model for COVID-19: The PERIL Prospective Cohort Study. Future Virology. 18(15). 991–999.
12.
Zahid, Muhammad, Adeel Ahmad Khan, Fateen Ata, et al.. (2023). Medical Admission Prediction Score (MAPS); a simple tool to predict medical admissions in the emergency department. PLoS ONE. 18(11). e0293140–e0293140.
13.
Habas, Elmukhtar, et al.. (2022). Hyponatremia and SARS-CoV-2 infection: A narrative review. Medicine. 101(32). e30061–e30061. 12 indexed citations
15.
Habas, Elmukhtar, et al.. (2021). Reno-Cardiac Syndrome (RCS): A Clinical Review. International Journal of Science and Research (IJSR). 10(6). 1705–1712.
16.
Elzouki, Abdel‐Naser, et al.. (2020). Management of diabetic ketoacidosis in adults: A narrative review. Saudi Journal of Medicine and Medical Sciences. 8(3). 165–165. 40 indexed citations
17.
Naushad, Vamanjore A, et al.. (2020). Endoscopic Findings in Patients With Uninvestigated Dyspepsia: A Retrospective Study From Qatar. Cureus. 12(10). e11166–e11166. 3 indexed citations
18.
Danjuma, Mohammed, et al.. (2019). Novel biomarkers for potential risk stratification of drug induced liver injury (DILI). Medicine. 98(50). e18322–e18322. 14 indexed citations
19.
Elzouki, Abdel‐Naser, et al.. (2018). Incidence and epidemiological features of acute pancreatitis among adult inhabitants in Qatar. The Turkish Journal of Gastroenterology. 30(1). 95–100. 7 indexed citations
20.
Khan, Fahmi Yousef & Abdel‐Naser Elzouki. (2014). Clostridium difficile infection: a review of the literature. Asian Pacific Journal of Tropical Medicine. 7. S6–S13. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026